Author: Laila Zulfa

Boston Scientific has initiated a comprehensive recall and permanent discontinuation of its Imager II Flush Angiographic Catheters following the discovery of a manufacturing defect that could lead to life-threatening complications for patients. The medical technology giant confirmed that certain lots of the device were produced with insufficient levels of stabilizing agents in the catheter tip,…

In a significant legal blow to one of the leaders in the liquid biopsy market, a U.S. federal court has issued a final judgment confirming that Guardant Health willfully infringed upon two foundational patents related to high-accuracy DNA sequencing. The ruling, which follows a multi-year legal battle involving TwinStrand Biosciences and the University of Washington,…

The landscape of diabetes management in the United States is standing on the precipice of a monumental shift as the Centers for Medicare and Medicaid Services (CMS) prepares to decide on the expansion of coverage for continuous glucose monitors (CGMs). For years, these wearable sensors, which provide real-time blood sugar readings to smartphones or dedicated…

Abbott has announced the achievement of a significant regulatory milestone with the receipt of the CE Mark for its Amulet 360 Left Atrial Appendage (LAA) closure system, signaling a new phase of competition in the rapidly expanding structural heart market. The approval allows the medical device giant to market its latest generation LAA occlusion technology…

Boston Scientific remains gripped by a significant network outage that has paralyzed critical operations, including manufacturing and global product distribution, following a sophisticated cyberattack identified earlier this week. The medical technology giant, which plays a pivotal role in the global supply chain for life-saving devices, confirmed in a late-Thursday update that the breach has severely…

Medtronic, a global leader in medical technology, has initiated a high-priority recall of its Bravo pH monitoring capsules for the second time in a two-year span, citing a significant mechanical fault that poses severe risks to patient safety, including potential airway obstruction and internal lacerations. The recall, which impacts the Bravo Calibration-Free (CF) capsules, was…

The Advanced Research Projects Agency for Health (ARPA-H), a specialized agency within the United States Department of Health and Human Services, has announced a significant investment of up to $175.3 million to accelerate the development of next-generation medical robotics. At the center of this initiative is a collaborative effort led by global health technology leader…

Johnson & Johnson’s MedTech division, specifically its subsidiary Abiomed, has initiated a field safety corrective action involving the Automated Impella Controller (AIC), a critical external component used to manage the world’s smallest heart pumps. The recall, which was communicated to healthcare providers in an urgent notification dated August 12, addresses a technical malfunction where the…

Cleveland Diagnostics, a commercial-stage biotechnology company specializing in next-generation oncology diagnostics, has officially appointed Valerie Dixon as its Chief Financial Officer. The strategic hire comes at a pivotal moment for the Ohio-based firm as it transitions from a research-intensive entity into a high-growth commercial organization. Dixon, a veteran of both the financial services and venture…

Boston Scientific Corporation, a global leader in medical technology, officially disclosed on Wednesday that it has fallen victim to a sophisticated cyberattack that has significantly compromised its internal information technology systems. The breach, which was first identified by the company on Tuesday, August 25, 2026, has resulted in a widespread disruption of global operations, specifically…